Geriatric Medicines Market [By Therapeutic Category (Analgesics, Antihypertensive, Statins, Antidiabetics, Proton Pump Inhibitor, Anticoagulant, Antipsychotic, and Antidepressant); By Therapeutic Conditions (Cardiovascular, Arthritis, Neurological, Cancer, Osteoporosis, and Respiratory); and by Regions (North America - U.S., Canada; Europe - Germany, UK, France, Italy, Russia; Asia-Pacific - China, India, Japan, Australia; Latin America - Brazil, Mexico; Middle East & Africa)]: Market size & Forecast, 2018 – 2026

Table of Contents

1. Overview and Scope
   1. Research goal & scope
   2. Research assumptions
   3. Research Methodology
      1. Primary data sources
      2. Secondary data sources
   4. Key take-aways
   5. Stakeholders
2. Executive Summary
   1. Market Definition
   2. Market Segmentation
3. Geriatric Medicines Market Insights
   1. Geriatric Medicines – Industry snapshot
   2. Geriatric Medicines - Ecosystem analysis
   3. Geriatric Medicines Market dynamics
      1. Geriatric Medicines – Market Forces
         1. Geriatric Medicines Market driver analysis
         2. Geriatric Medicines Market restraint/challenges analysis
         3. Geriatric Medicines Market opportunity analysis
   4. Industry analysis - Porter's five force
      1. Bargaining power of supplier
      2. Bargaining power of buyer
      3. Threat of substitute
      4. Threat of new entrant
      5. Degree of competition
   5. Geriatric Medicines Market PEST analysis, 2017
      1. Geriatric Medicines Industry trends
      2. Competitive Ranking Analysis
4. Geriatric Medicines Market Size and Forecast by Therapeutic Category
   1. Key findings
   2. Analgesics
      1. Global market estimates and forecasts, 2017 – 2026
   3. Antihypertensives
      1. Global market estimates and forecasts, 2017 – 2026
   4. Statins
      1. Global market estimates and forecasts, 2017 – 2026
   5. Antidiabetics
      1. Global market estimates and forecasts, 2017 – 2026
   6. Proton Pump Inhibitor
      1. Global market estimates and forecasts, 2017 – 2026
   7. Anticoagulant
      1. Global market estimates and forecasts, 2017 – 2026
   8. Antipsychotic
      1. Global market estimates and forecasts, 2017 – 2026
   9. Antidepressant
      1. Global market estimates and forecasts, 2017 – 2026
5. Geriatric Medicines Market Size and Forecast by Therapeutic Condition
   1. Key findings
   2. Cardiovascular
      1. Global market estimates and forecasts, 2017 - 2026
   3. Arthritis
      1. Global market estimates and forecasts, 2017 – 2026
   4. Neurological
      1. Global market estimates and forecasts, 2017 – 2026
   5. Cancer
      1. Global market estimates and forecasts, 2017 - 2026
   6. Osteoporosis
      1. Global market estimates and forecasts, 2017 – 2026
   7. Respiratory
      1. Global market estimates and forecasts, 2017 – 2026
6. Geriatric Medicines Market Size and Forecast by Regions
   1. Key findings
   2. North America
      1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026
      2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026
      3. U.S.
         1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026
         2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026
      4. Canada
         1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026
         2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026
   3. Europe
      1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026
      2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026
      3. Germany
         1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026
         2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026
      4. UK
         1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026
         2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026
      5. France
         1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026
         2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026
      6. Italy
         1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026
         2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026
   4. Asia Pacific
      1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026
      2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026
      3. China
         1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026
         2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026
      4. India
         1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026
         2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026
      5. Japan
         1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026
         2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026
      6. Australia
         1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026
         2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026
   5. Latin America
      1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026
      2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026
      3. Brazil
         1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026
         2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026
      4. Mexico
         1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026
         2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026
   6. Middle East & Africa
      1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026
      2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026
7. Company Profiles
   1. GlaxoSmithKline Plc
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   2. BoehringerIngelheim GmbH
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   3. Novartis AG
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   4. Bristol-Myers Squibb Company
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   5. Pfizer, Inc.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   6. Eli Lilly and Company
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   7. Abbott Laboratories Inc.
      1. Overview
      2. Financials
      3. Product Benchmarking
   8. AstraZeneca plc
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   9. Merck & Company Inc.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   10. Sanofi S.A.
       1. Overview
       2. Financials
       3. Product Benchmarking
       4. Recent Developments